Literature DB >> 3166537

The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer.

A M Hirschl1, E Hentschel, K Schütze, H Nemec, R Pötzi, A Gangl, W Weiss, M Pletschette, G Stanek, M L Rotter.   

Abstract

The efficacy of various antimicrobial and anti-ulcer agents on the elimination of Campylobacter pylori in duodenal ulcer patients was investigated. Ranitidine, cimetidine, pirenzepine, aluminium phosphate gel as well as combinations of H2-receptor antagonists or pirenzepine + penicillin V, ciprofloxacin, ofloxacin, phenyl-mercuryborate or rifampicin had no influence on C. pylori in vivo. Short term elimination of C. pylori was achieved in 3/15 patients treated with ranitidine + bacampicillin and in 1/5 treated with cimetidine + metronidazole. This elimination was accompanied by a significant reduction of polymorphonuclear infiltration of the antral mucosa. Development of bacterial resistance was observed in patients with additional quinolones, metronidazole and rifampicin but not in patients treated with betalactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166537     DOI: 10.3109/00365528809091718

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  13 in total

1.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

2.  In vitro selection of resistant Helicobacter pylori.

Authors:  C E Haas; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

3.  Oral immunization against Helicobacter pylori.

Authors:  S J Czinn; J G Nedrud
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

4.  Comparison of different antigen preparations in an evaluation of the immune response to Campylobacter pylori.

Authors:  A M Hirschl; M Pletschette; M H Hirschl; J Berger; G Stanek; M L Rotter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

5.  Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy.

Authors:  G Otto; J G Fox; P Y Wu; N S Taylor
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Receptor-mediated adherence of Campylobacter pylori to mouse Y-1 adrenal cell monolayers.

Authors:  D G Evans; D J Evans; D Y Graham
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats.

Authors:  H Endo; H Yoshida; N Ohmi; S Higuchi
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis.

Authors:  U Blecker; F Renders; S Lanciers; Y Vandenplas
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

Review 9.  Effects of acid suppression on microbial flora of upper gut.

Authors:  N D Yeomans; R W Brimblecombe; J Elder; R V Heatley; J J Misiewicz; T C Northfield; A Pottage
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 10.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.